news
NEWS MANAGEMENT
Editor-in-chief Vicky Diaz-Camacho
Managing editor
Kate Miller
Brand & creativity manager Hallie Wilson
Digital operations editor Anissa Fritz
ADVERTISING MANAGEMENT
Business Manager
Gage Brock
Sales manager Katie Bell
SECTION EDITORS
News editor Kelly Cordingley
Associate news editor Cassidy Ritter
Sports editor Scott Chasen
Associate sports editor Shane Jackson
Arts & culture editor Ryan Wright
Associate arts & culture editor Christian Hardy
Visuals editor &
design chief
Roxy Townsend
Chief photographer Caroline Fiss
Investigations editor Miranda Davis
ADVISER
Sales and marketing adviser Jon Schlitt
The University Daily Kansan is the student newspaper of the University of Kansas. The first copy is paid through the student activity fee. Additional copies of the Kansan are 50 cents. Subscriptions can be purchased at the Kansan business office, 2051A Dole Human Development
Center, 1080 Sunnyside Aveni
Lawrence, KS., 66045.
The University Daly Kansan (ISSN 0746-4967) is published on Mondays and Fridays during the academic year except fall break, spring break and exams. It is published weekly during the summer session excluding holidays. Annual subscriptions by mail are $250 plus tax. Send address changes to The University Daily Kansan, 2015A Dole Human Development Center, 1000 Surrey Avenue
KANSAN MEDIA PARTNERS
Check out KUH-JV on Wowi of Kansas Channel 31 in Lawrence for more on what you read in today's Kansan and other news. Also see KUHJ's website at
KJHK is the student voice in radio. Whether it's rock 'n' roll or reggae, sports or special events, KJHK is for you.
2000 Dole Human Development Center
1000 Sunnyside Avenue
Lawrence, Kan. 66045
editor@kansan.com
www.kansan.com
Newsroom: (785) 766-1491
Advertising: (785) 864-4358
ENGAGE WITH
US >>
ANYWHERE.
@KANSANNEWS
/THEKANSAN
KANSAN.NEWS
@UNIVERSITY
DAILYKANSAN
FILE PHOTO/Kansan
KU Climate Survey measures student opinion of campus experience
KATIE HAYES
@Katie_Hayeso
The University is now in the second part of phase one for the Campus Climate Study.
Staff and students on Jan. 28 touched base on the
This phase includes conducting focus groups at the University to gear the survey toward students, said Nathan Thomas, vice provost for Diversity and Equity. The study exists to gauge the University's living, learning and working environments, according to an email sent from Sara Rosen, interim provost.
"The process begins with small group discussions of selected individuals that will help shape a survey that all will be invited to complete," read Rosen's email.
KU Climate Study website through an official email from the Office of the Provost.
The survey will include the Lawrence campus, Edwards Campus and Medical Center. The University Campus Climate Study task force is conducting the evaluation and is led by Thomas, along with Associate Vice Provost for Human Resource Management Mike Rounds and Doug Girod, executive vice chancellor of KUMC. Student representatives from various groups will also participate.
The study will tackle a series of aspects, including, respect and collegiality communication, collaboration and cooperation overall work and academic environment, and diversity, equity and inclusion according to the Climate Study website.
Thomas said the task force is an integral part of the study and will facilitate how the campus will move forward after the information is gathered.
The survey will be accessible through a website that will launch Fall of 2016 Bonifield said.
Saida Bonifield, project manager, said there needs to be between 30 to 40 percent participation from the University to produce generalized results. Consultants will analyze the results of the study, and use this information to improve many factors in the KU community, according to the website.
Bonifield said the survey will be ongoing project to effectively accumulate information and data on
KU-affiliated company receives grant for cancer-fighting drug
MATT OSTROWSKI
@motto1222
Contributed Photo Daniel Aires, president and CEO of HylaPharm
In 2015, one cancer-related death occurred every 54 seconds in the United States, according the American Cancer Society. This led to a total of nearly 600,000 deaths.
But one local company is collaborating with the University to change that.
HylaPharm, a cancer chemotherapy development company, was awarded a $300,000 contract on Monday from the Small Business Innovation Research program to help develop its cancer fighting
drugs.
The program funds a limited amount of startup companies similar to HylaPharm, according to program's website. The National Cancer Institute presented the award to HylaPharm.
"While the money is nice, the bigger deal from our perspective is the seal of approval we're getting from the National Cancer Institute," said Daniel Aires, president and CEO of HylaPharm.
HylaPharm is led by Aires, along with chief operating officer Laird Forrest, a University faculty member. Several University researchers contributed to the project as well.
"This allows it to be injected right into the cancer, so we get the drug where we want it," he said. "After that, the drug actuary travels to the lymph nodes, which is the same place that these cancers initially metastasize."
HylaPharm received the award based upon its development of what Aires referred to as a "game changer" in cancer treatment. HylaPharm researchers combined cisplatin, a cancer drug from the late 70s, with hyaluronan, a more modern drug.
The difference between the two drugs is that instead of combining hyaluronan and cisplatin, researchers will combine hyaluronan and a drug called rapamycin, a drug more commonly used to help organ rejection.
With that accomplished, Aires and Forrest said, HylaPharm will now use the award to develop a breast cancer treatment drug.
"We look in dogs because their cancer is a whole lot like people's," Forrest said. "We actually have treated and cured a few people's actual pets."
"It targets the so-called 'cancer stem cells' which are the ones that most chemotherapy doesn't do very well with." Aires said.
After four years of testing and refining the drug, the HylaPharm team successfully used it to treat cancer in dogs, said Forrest.
effects, but Aires said now it's not an issue.
The issue with rapamycin in the past has been its side
"The advantage of our method is we get a whopping dose where it's needed, so we can start to show some effectiveness against the cancer," he said. "But we can do that without causing the kinds of side effects that limit its use."
HylaPharm will apply for additional funding with the Small Business Innovation Research program in hopes of taking the next step in its cancer research. Forrest hopes that within five years HylaPharm will have taken this drug to the advanced stages of testing, where it and other treatments would be used on humans.
"I would hope in 10 years that we have a product out there benefiting some people."
In the more distant future, however, he has an even bigger goal in mind.
Edited by Deanna Ambrose
how University-specific environments can have an impact on the different aspects of life.
The results for the climate survey are expected to be completed by the spring of 2017, according to the website.
No quizzes, no papers, no grades...just fun!
Edited by Deanna Ambrose
Knitting & Crochet Classes Starting Now
Enroll at www.yarnbarn-ks.com YARN BARN 930 Massachusetts
MONDAY, FEB. 1
OPEN MIC
TUESDAY, FEB. 2
BIRTHDAY
BASH
WEDNESDAY, FEB. 3
KJHK PRESENTS
YO LA TENGO
THURSDAY, FEB. 4
THURSDAY, FEB. 4
BASS HERTZ
TAKEOVER
FRIDAY, FEB. 5
INTELLIGENT SOUND
FEBRUARY 6
RUMPKE
MOUNTAIN
BOYS
TYLER GREGORY
SMACKDOWN
THE BAND THAT SAVED THE WORLD FEBRUARY 10
FEBRUARY 8 DESMOND JONES
TRIVIA
COFFEE BAND
FOUR ARM SHIVER
88ER
FEBRUARY 10
LINEAR
SYMMETRY
FEBRUARY 11
RAGGED UNION
PICKIN' ON ZEPPELIN
WWW.THEBDTTLENECKLIVE.COM
+